Future Science Group
Browse
Supplementary material.docx (20.45 kB)

Nanocarrier-based delivery of arsenic trioxide for hepatocellular carcinoma therapy - Supplementary dataset

Download (20.45 kB)
dataset
posted on 2023-02-15, 11:19 authored by Jiang Sun, Mengying Cheng, Tingxian Ye, Bin Li, Yinghui Wei, Hangsheng Zheng, Hongyue Zheng, Meiqi Zhou, Ji-Gang Piao, Fanzhu Li

Hepatocellular carcinoma (HCC) poses a severe threat to human health and economic development.

Despite many attempts at HCC treatment, most are inevitably affected by the genetic instability and

variability of tumor cells. Arsenic trioxide (ATO) has shown to be effective in HCC. However, timeconsuming

challenges, especially the optimal concentration in tumor tissue and bioavailability of ATO,

remain to be overcome for its transition from the bench to the bedside. To bypass these issues,

nanotechnology-based delivery systems have been developed for prevention, diagnosis, monitoring and

treatment in recent years. This article is a systematic overview of the latest contributions and detailed

insights into ATO-loaded nanocarriers, with particular attention paid to strategies for improving the

efficacy of nanocarriers of ATO.

Funding

National Natural Science Foundation of China, (Grant / Award Number: 'NO.82074027','No.81873014')

Natural Science Foundation of Zhejiang Province, (Grant / Award Number: 'NO.LZ21H280001')

History

Usage metrics

    Nanomedicine

    Categories

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC